ロード中...
Performance characteristics between TDx®FLx and TBA™-25FR for the therapeutic drug monitoring of methotrexate
BACKGROUND: High-dose methotrexate (HDMTX) is used in the treatment of certain malignancies, including leptomeningeal metastases, systemic non-Hodgkin lymphoma, acute lymphoblastic leukemia, and osteosarcoma. High circulating levels of methotrexate can cause severe myelosuppression. The present stud...
保存先:
| 出版年: | J Pharm Health Care Sci |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4782285/ https://ncbi.nlm.nih.gov/pubmed/26958349 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40780-016-0042-y |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|